ESSO SURVEY

Segui SICOGood Morning, On behalf of ESSO, we would like to invite you to take part in a survey exploring practices in the management of neuroendocrine tumors, including insights into the use of Peptide Receptor Radionuclide Therapy (PRRT). The survey is open to all...